PHARMACOKINETICS AND TISSUE DISTRIBUTION OF DOXORUBICIN ENCAPSULATED IN STABLE LIPOSOMES WITH LONG CIRCULATION TIMES

被引：182
|
作者：
GABIZON, A
SHIOTA, R
PAPAHADJOPOULOS, D
机构：
[1] LIPOSOME TECHNOL INC, MENLO PK, CA USA
[2] UNIV CALIF SAN FRANCISCO, CANC RES INST, SAN FRANCISCO, CA 94143 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 19期
关键词：
D O I：
10.1093/jnci/81.19.1484
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1484 / 1488
页数：5
相关论文
共 50 条
  • [31] Plasma Pharmacokinetics and Tissue Distribution of Doxorubicin in Rats following Treatment with Astragali Radix
    Huang, Yin
    Yang, Fang
    Guo, Linling
    Xu, Yan
    Yu, Xiaxia
    Zhang, Zunjian
    Zhang, Yuxin
    PHARMACEUTICALS, 2022, 15 (09)
  • [32] PROLONGATION OF THE CIRCULATION TIME OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING A POLYETHYLENE GLYCOL-DERIVATIZED PHOSPHOLIPID - PHARMACOKINETIC STUDIES IN RODENTS AND DOGS
    GABIZON, AA
    BARENHOLZ, Y
    BIALER, M
    PHARMACEUTICAL RESEARCH, 1993, 10 (05) : 703 - 708
  • [33] Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes
    T. O. Harasym
    Pieter R. Cullis
    Marcel B. Bally
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 309 - 317
  • [34] Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes
    Harasym, TO
    Cullis, PR
    Bally, MB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (04) : 309 - 317
  • [35] Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome®)
    Fielding, RM
    Lewis, RO
    Moon-McDermott, L
    PHARMACEUTICAL RESEARCH, 1998, 15 (11) : 1775 - 1781
  • [36] Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-Clearance Liposomes (MiKasome®)
    Robert M. Fielding
    Ramilla O. Lewis
    Lotus Moon-McDermott
    Pharmaceutical Research, 1998, 15 : 1775 - 1781
  • [37] Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
    Kim, Tae Hwan
    Shin, Soyoung
    Yoo, Sun Dong
    Shin, Beom Soo
    MOLECULES, 2018, 23 (02):
  • [38] Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically-based pharmacokinetic modeling
    Lee, Jong Bong
    Zhou, Simon
    Chiang, Manting
    Zang, Xiaowei
    Kim, Tae Hwan
    Kagan, Leonid
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (4-5) : 192 - 205
  • [39] Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice (vol 43, pg 1, 1999)
    Newman, MS
    Colbern, GT
    Working, PK
    Engbers, C
    Amantea, MA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 524 - 524
  • [40] PHARMACEUTICAL AND BIOLOGICAL PROPERTIES OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES (L-ADM) - THE EFFECT OF REPEATED ADMINISTRATION ON THE SYSTEMIC PHAGOCYTIC-ACTIVITY AND PHARMACOKINETICS
    YACHI, K
    KIKUCHI, H
    SUZUKI, N
    ATSUMI, R
    AONUMA, M
    KAWATO, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (08) : 653 - 667
12345